Nektar Therapeutics (NKTR) Share-based Compensation Growth (5y) (2015 - 2026)
Nektar Therapeutics (NKTR) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.47% |
| Sep 30, 2025 | -33.53% |
| Jun 30, 2025 | -31.65% |
| Mar 31, 2025 | 12.82% |
| Dec 31, 2024 | 23.59% |
| Sep 30, 2024 | -26.35% |
| Jun 30, 2024 | -26.06% |
| Mar 31, 2024 | -25.06% |
| Sep 30, 2023 | -18.94% |
| Jun 30, 2023 | -17.35% |
| Mar 31, 2023 | -12.87% |
| Dec 31, 2022 | 2.07% |
| Sep 30, 2022 | 7.22% |
| Jun 30, 2022 | 6.51% |
| Mar 31, 2022 | 20.69% |
| Sep 30, 2021 | 31.94% |
| Jun 30, 2021 | 30.51% |
| Mar 31, 2021 | 30.30% |
| Sep 30, 2020 | 37.81% |
| Jun 30, 2020 | 38.66% |